Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylationGlenn S. Van Aller, Ryan G. Kruger, Roland S. Annan et al.|Epigenetics|2012Cited by 174
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinaseJeffrey D. Carson, Lusong Luo, Glenn Van Aller et al.|Biochemical Journal|2007Cited by 119
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesLata T. Gooljarsingh, Peter J. Tummino, Christine Fernandes et al.|Proceedings of the National Academy of Sciences|2006Cited by 119
C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding siteJianhong Ma, Zhihong Lai, John D. Martin et al.|Archives of Biochemistry and Biophysics|2010Cited by 69
Characterization of PI3K class IA isoforms with regulatory subunit p55α using a scintillation proximity assayGlenn S. Van Aller, Lusong Luo, Jeff D. Carson et al.|Analytical Biochemistry|2008Cited by 10